The intraductal component of breast cancer is poorly responsive to neo-adjuvant chemotherapy.

Oncology reports

Volumn 9, Issue 5, 2002, Pages 1027-1031

  Wu, Wenwen ^a   Kamma, Hiroshi ^a   Ueno, E ^a   Fujiwara, Masachika ^a   Satoh, Hiroaki ^a   Hara, Hisato ^a   Yashiro, Tohru ^a   Aiyoshi, Yuji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; DRUG DERIVATIVE; FLUOROURACIL; KI 67 ANTIGEN; PACLITAXEL; TAXOID;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL DIVISION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NICK END LABELING; PAGET NIPPLE DISEASE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL DIVISION; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KI-67 ANTIGEN; MIDDLE AGED; PACLITAXEL; TAXOIDS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0036730946     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.9.5.1027     Document Type: Article

References (0)